Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04062227 · ClinicalTrials.gov registry record

Mindfulness Based Dementia Care Study

A clinical trial, sponsored by HealthPartners Institute.

Completed
Registry status
26
Enrollment target

NCT04062227: Completed study, sponsored by HealthPartners Institute.

NCT04062227 is a clinical trial that has completed, run by HealthPartners Institute. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04062227 has completed, sponsored by HealthPartners Institute.

COMPLETED
Registry status
26 participants
Enrollment target

Study Summary

Mindfulness based stress reduction (MBSR) refers to a particular type of attention focused on the present moment, non-judgmental awareness, and acceptance of that experience with openness and curiosity. Mindfulness training was designed to enhance the range and use of coping skills, decrease levels of stress, improve mood, and reduce tendencies to react in maladaptive ways 1-3. Investigators are evaluating a new program, called the Mindfulness Based Dementia-Care (MBDC) in caregivers (CG) for dementia, which combines the traditional approaches with education. The overall objective of this study is to evaluate the program and explore the potential benefits of the Mindfulness Based Dementia-Care (MBDC) program. Investigators are conducting a prospective, pre-post, observational study with members participating in the MBDC program.

Primary Outcome

The Perceived Stress Scale (PSS) scores on a total score. The range of the PSS is 0-40 points. A lower score is indicative of lower stress.

Trial Details

FieldValue
Enrollment Target 26 participants
Start Date 2019-01-25
Est. Completion 2023-03-02
HealthPartners Institute

146 total trials

What the finished NCT04062227 record still lists

NCT04062227 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 26 participants, a relatively small participant target.

The record links to 0 conditions, and to 0 interventions.

NCT04062227 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04062227 about?

NCT04062227 is a clinical study titled "Mindfulness Based Dementia Care Study". Mindfulness based stress reduction (MBSR) refers to a particular type of attention focused on the present moment, non-judgmental awareness, and acceptance of that experience with openness and curiosity. Mindfulness training was designed to enhance the range and use of coping skills, decrease levels ...

What is the current status of trial NCT04062227?

This trial is currently completed. The enrollment target is 26 participants. The study started on 2019-01-25. Estimated completion is 2023-03-02.

Who is sponsoring clinical trial NCT04062227?

This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02646475 · 26 participants · Phase 1

    Metabolic Effects of Angiotensin-(1-7)

  • NCT03603223 · 26 participants · Phase 2

    Pembrolizumab in Treating Participants With Leukoplakia

  • NCT04063592 · 26 participants · NA

    AMI Construction in Lower Extremity Residual Limbs

  • NCT04906460 · 26 participants · Phase 1

    Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04062227, the US trial registry maintained by the National Library of Medicine. NCT04062227 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.